News
VVMF announces strategic collaboration with OXB, with view to licencing AAV and lentiviral vector platforms as first priority
Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first commercial viral vector Contract Development and Manufacturing Organisation (CDMO), has commenced a strategic collaboration with OXB…
Australia’s First Clinical and Commercial-Scale Viral Vector CDMO, VVMF, Opens in Sydney
Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first and only clinical and commercial-scale viral vector Contract Development and Manufacturing Organisation (CDMO), was officially opened…
Viral Vector Manufacturing Facility (VVMF) and Chimeric Therapeutics sign Letter of Intent to provide GMP manufacturing of viral vectors in Australia for global clinical applications
Viral Vector Manufacturing Facility Pty Ltd (VVMF) and Chimeric Therapeutics (ASX:CHM, “Chimeric”) have cosigned a Letter of Intent (LOI) to enter a strategic supplier relationship…
Viral Vector Manufacturing Facility (VVMF) at the Cell & Gene Meeting on the Mesa, 2025
Viral Vector Manufacturing Facility Pty Ltd (VVMF) announces its participation at the Cell & Gene Meeting on the Mesa 2025, October 6-8 2025, at the…
Diversity Disclosure 2024-2025
Viral Vector Manufacturing Facility Pty. Ltd. (“VVMF”, “the Company”) has adopted aDiversity Policy. This Policy requires disclosure regarding: The VVMF Board of Directors (“Board”) has…
Viral Vector Manufacturing Facility (VVMF) and Cell Therapies enters strategic collaboration
Viral Vector Manufacturing Facility Pty. Ltd. (VVMF) and Cell Therapies Pty Ltd. have co-signed a memorandum of understanding (MoU) to explore strategic collaboration opportunities aimed…
Viral Vector Manufacturing Facility (VVMF) at Bio International Conference 2025
Viral Vector Manufacturing Facility Pty Ltd (VVMF) announces its participation at the Bio International Conference 2025, June 16-19 2025, at the Boston Convention & Exhibition…
Viral Vector Manufacturing Facility (VVMF) at BIO KOREA 2025
Viral Vector Manufacturing Facility Pty Ltd (VVMF) is set to participate in BIO KOREA 2025, May 7-9 2025, bringing its expertise in viral vector manufacturing…
Diversity Disclosure 2023-2024
Viral Vector Manufacturing Facility Pty. Ltd. (“VVMF”, “the Company”) has adopted a Diversity Policy. This Policy requires disclosure regarding: The VVMF Board of Directors (“Board”)…
VVMF announces appointment of the Board
The Viral Vector Manufacturing Facility Pty Ltd (VVMF) is delighted to announce the following appointments to the Board. Sue MacLeman: VVMF Board Chair and Non-Executive…
VVMF announces the appointment of Mr Stephen Thompson as the inaugural Chief Executive Officer
The Viral Vector Manufacturing Facility Pty Ltd (VVMF) Board is delighted to announce the appointment of Mr. Stephen Thompson as the inaugural Chief Executive Officer…